IFGL Refractories
- P/E
- 30.38
Key Fundamentals
MicrocapIndustrial ProductsCapital GoodsPrice-based figures as of · EPS basis: Consolidated · TTM
- ROCE
- 4.92%
- Debt to Equity
- 0.18
- EPS (TTM)
- ₹5.68
- Book Value
- ₹163.00
- Market Cap
- —
- P/E (TTM)
- 30.38
- P/B
- 1.06
- ROE
- 3.22%
- Dividend Yield
- 1.29%
- EBITDA
- ₹146 Cr
- 52W High
- ₹247.90
- 52W Low
- ₹119.68
- Day Range
- ₹165.62 – ₹174.00
- Volume
- 13,840
Peer Comparison
Industrials › Industrial Products › Electrodes & Refractories
| ₹741.45 | 68.02 | ₹14,021 Cr | 2.42 | 0.93% | 3.11% | 4.58% | ₹3,029 Cr | ₹209 Cr | |
| ₹288.18 | 15.49 | ₹8,779 Cr | 1.99 | 1.41% | 7.42% | 8.35% | ₹2,639 Cr | ₹358 Cr | |
| ₹1,808.80 | 117.84 | ₹8,033 Cr | 29.50 | 0.06% | 24.30% | 30.30% | ₹315 Cr | ₹71 Cr | |
| ₹370.30 | 29.37 | ₹7,540 Cr | 4.30 | 0.41% | 15.00% | 21.30% | ₹2,134 Cr | ₹257 Cr | |
| ₹363.85 | — | ₹7,413 Cr | 2.11 | 0.70% | 2.83% | 6.46% | ₹4,074 Cr | −₹353 Cr | |
| ₹1,336.90 | 100.97 | ₹2,745 Cr | 19.12 | 0.00% | 27.80% | 34.80% | ₹154 Cr | ₹29 Cr | |
| ₹172.54 | 30.38 | ₹1,228 Cr | 1.06 | 1.29% | 3.22% | 4.92% | ₹1,953 Cr | ₹41 Cr | |
| Median 7 companies | ₹370.30 | 49.20 | ₹7,540 Cr | 2.42 | 0.70% | 7.42% | 8.35% | ₹2,134 Cr | ₹71 Cr |
Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company.
Tapetide Score
Data-driven rating, 0–100, as of . How it works →
Overall score
Data confidence 100/100
Category scores
- Quality
- 49
- Average
- Returns, margins, earnings quality 22% weight
- Valuation
- 62
- Good
- Cheap vs sector & own history 24% weight
- Growth
- 46
- Average
- Sales & profit trajectory 9% weight
- Financial Health
- 47
- Average
- Solvency, leverage, coverage 9% weight
- Momentum
- 29
- Poor
- Trend strength, vol-adjusted 12% weight
- Ownership
- 38
- Weak
- FII/DII/promoter flows 24% weight
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
Strengths
2- Stock is trading at 1.09 times its book value
- Company has been maintaining a healthy dividend payout of 44.8%
Weaknesses
1- Company has a low return on equity of 4.92% over last 3 years.
Technical Indicators
| Group | Signal | Bearish | Neutral | Bullish |
|---|---|---|---|---|
| Overall | Strong Bearish | 10 | 5 | 4 |
| Oscillators | Neutral | 2 | 5 | 2 |
| Moving Averages | Strong Bearish | 8 | 0 | 2 |
Oscillators
Neutral
Overall
Strong Bearish
Moving Averages
Strong Bearish
Key readings
- RSI (14)
- 45.62
- Neutral
- MACD (12,26,9)
- −6.62
- Bullish
- SMA (50)
- 190.23
- Bearish
- SMA (200)
- 185.85
- Bearish
As of
Growth Rate
From the financial statements below. 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Jun 2026 against Jun 2025.
Revenue
| 5Y | +13.13% |
|---|---|
| 3Y | +10.97% |
| 1Y | +14.58% |
| TTM | +15.36% |
Net profit
| 5Y | −11.91% |
|---|---|
| 3Y | −23.77% |
| 1Y | −18.60% |
| TTM | +41.38% |
Operating cash flow
| 5Y | −14.64% |
|---|---|
| 3Y | +118.98% |
| 1Y | +125.00% |
| TTM | — |
TTM: Reported once a year, so there is no trailing-twelve-month figure.
Operating margin· change in pp
| 5Y | −8.13 pp |
|---|---|
| 3Y | −3.81 pp |
| 1Y | −0.63 pp |
| TTM | −0.02 pp |
Revenue by year
| Mar 2017 | ₹766 Cr |
|---|---|
| Mar 2018 | ₹835 Cr |
| Mar 2019 | ₹950 Cr |
| Mar 2020 | ₹917 Cr |
| Mar 2021 | ₹1,022 Cr |
| Mar 2022 | ₹1,260 Cr |
| Mar 2023 | ₹1,386 Cr |
| Mar 2024 | ₹1,639 Cr |
| Mar 2025 | ₹1,653 Cr |
| Mar 2026 | ₹1,894 Cr |
Net profit by year
| Mar 2017 | ₹50.00 Cr |
|---|---|
| Mar 2018 | ₹47.00 Cr |
| Mar 2019 | ₹50.00 Cr |
| Mar 2020 | ₹19.00 Cr |
| Mar 2021 | ₹66.00 Cr |
| Mar 2022 | ₹77.00 Cr |
| Mar 2023 | ₹79.00 Cr |
| Mar 2024 | ₹82.00 Cr |
| Mar 2025 | ₹43.00 Cr |
| Mar 2026 | ₹35.00 Cr |
Quarterly Results
₹ Cr| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 424 | 456 | 366 | 394 | 415 | 411 | 379 | 449 | 454 | 489 | 469 | 483 | 512 |
| Expenses | 368 | 388 | 370 | 359 | 368 | 379 | 362 | 415 | 418 | 451 | 446 | 444 | 475 |
| Operating Profit | 56 | 68 | −4 | 35 | 46 | 33 | 17 | 33 | 36 | 38 | 23 | 39 | 37 |
| OPM % | 13% | 15% | −1.1% | 9% | 11% | 8% | 4.4% | 7% | 8% | 8% | 4.9% | 8% | 7% |
| Other Income | 3 | 4 | 4 | 7 | 7 | 4 | 3 | 4 | 3 | 2 | −3 | 2.91 | 3 |
| Interest | 3 | 2 | 3 | 3 | 3 | 3 | 4 | 4 | 5 | 4 | 4 | 4 | 3 |
| Depreciation | 16 | 16 | 16 | 17 | 17 | 18 | 18 | 20 | 19 | 20 | 20 | 21 | 14 |
| PBT | 41 | 54 | −18 | 21 | 33 | 15 | −2 | 13 | 15 | 17 | −4 | 17 | 23 |
| Tax % | 28% | 29% | −108% | 41% | 26% | 21% | 11% | 34% | 29% | 24% | −18% | 16% | 26% |
| Net Profit | 30 | 38 | 2 | 13 | 25 | 12 | −2 | 8 | 11 | 13 | −3 | 14 | 17 |
| EPS (₹) | 4.11 | 5.27 | 0.21 | 1.74 | 3.42 | 1.68 | −0.3 | 1.17 | 1.5 | 1.76 | −0.43 | 1.98 | 2.37 |
Profit & Loss
₹ Cr| Particulars | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 766 | 835 | 950 | 917 | 1,022 | 1,260 | 1,386 | 1,639 | 1,653 | 1,894 | 1,953 |
| Expenses | 667 | 729 | 841 | 825 | 865 | 1,117 | 1,233 | 1,485 | 1,523 | 1,757 | 1,816 |
| Operating Profit | 99 | 106 | 109 | 92 | 157 | 143 | 153 | 155 | 130 | 137 | 137 |
| OPM % | 13% | 13% | 12% | 10% | 15% | 11% | 11% | 9% | 8% | 7% | 7% |
| Other Income | 4 | 4 | 4 | −10 | 19 | 16 | 13 | 18 | 17 | 4 | 4 |
| Interest | 5 | 4 | 4 | 4 | 3 | 3 | 5 | 11 | 13.75 | 15.83 | 14 |
| Depreciation | 44 | 44 | 46 | 48 | 49 | 51 | 56 | 64 | 73 | 80 | 74 |
| PBT | 55 | 63 | 64 | 30 | 124 | 104 | 106 | 98 | 60 | 45 | 53 |
| Tax % | 8% | 25% | 21% | 35% | 47% | 25% | 25% | 17% | 28% | 23% | — |
| Net Profit | 50 | 47 | 50 | 19 | 66 | 77 | 79 | 82 | 43 | 35 | 41 |
| EPS (₹) | 86.16 | 6.54 | 7 | 2.7 | 9.1 | 10.75 | 10.99 | 11.33 | 5.96 | 4.81 | 5.68 |
| Div. Payout % | 1% | 15% | 18% | 46% | 55% | 33% | 32% | 31% | 59% | 45% | — |
Balance Sheet
₹ Cr| Particulars | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 3 | 36 | 36 | 36 | 36 | 36 | 36 | 36 | 36 | 72 |
| Reserves | 650 | 716 | 759 | 773 | 854 | 898 | 969 | 1,036 | 1,071 | 1,103 |
| Borrowings | 84 | 112 | 89 | 65 | 64 | 99 | 160 | 174 | 213 | 209 |
| Other Liabilities | 158 | 134 | 135 | 150 | 230 | 253 | 261 | 244 | 298 | 284 |
| Total Liabilities | 894 | 999 | 1,019 | 1,024 | 1,184 | 1,286 | 1,426 | 1,490 | 1,618 | 1,667 |
| Fixed Assets | 471 | 461 | 454 | 440 | 416 | 422 | 500 | 517 | 593 | 610 |
| CWIP | 2 | 8 | 6 | 7 | 22 | 25 | 46 | 104 | 27 | 41 |
| Investments | 12 | 13 | 46 | 94 | 128 | 135 | 132 | 126 | 105 | 68 |
| Other Assets | 409 | 516 | 513 | 483 | 618 | 704 | 748 | 743 | 893 | 949 |
| Total Assets | 894 | 999 | 1,019 | 1,024 | 1,184 | 1,286 | 1,426 | 1,490 | 1,618 | 1,667 |
Cash Flow
₹ Cr| Particulars | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 28 | 41 | 109 | 150 | 139 | 4 | 6 | 152 | 28 | 63 |
| Investing | −9 | −40 | −70 | −50 | −97 | −26 | −118 | −115 | −34 | −13 |
| Financing | −4 | 18 | −37 | −66 | −5 | −7 | 50 | −24 | −4 | −58 |
| Net Cash Flow | 14 | 19 | 3 | 33 | 38 | −29 | −62 | 13 | −9 | −8 |
| Free Cash Flow | 15 | −2 | 72 | 126 | 108 | −61 | −130 | 18 | −44 | 0 |
| CFO/EBITDA | 48 | 53 | 114 | 163 | 101 | 21 | 23 | 113 | 42 | 66 |
Ratios
| Particulars | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 109 | 124 | 88 | 84 | 82 | 79 | 92 | 72 | 79 | 82 |
| Inventory Days | 94 | 94 | 120 | 113 | 129 | 154 | 153 | 132 | 179 | 152 |
| Days Payable | 118 | 109 | 95 | 99 | 119 | 111 | 94 | 79 | 104 | 86 |
| Cash Conversion Cycle | 85 | 110 | 112 | 98 | 91 | 122 | 151 | 126 | 154 | 148 |
| Working Capital Days | 68 | 83 | 75 | 72 | 68 | 80 | 94 | 75 | 83 | 86 |
| ROCE % | — | 8% | 8% | 6% | 14% | 11% | 10% | 9% | 6% | 5% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view IFGL Refractories insights
64 extracted metrics across FY10–FY27.
Documents
- Q1 FY27 concall · Aug 2026Transcript PPT Recording
- Q4 FY26 concall · Jun 2026Transcript PPT Recording
- Q3 FY26 concall · Feb 2026Transcript PPT Recording
- Q2 FY26 concall · Nov 2025Transcript PPT Recording
- Q1 FY26 concall · Aug 2025Transcript PPT
- 30 May 2026
- 14 Feb 2026
- 9 Aug 2025
- 25 Aug 2026
- 12 Jun 2025
- 26 Mar 2024
- 27 Jan 2022
- 5 Jan 2021
- General announcements 12 Oct 2026
Frequently Asked Questions about IFGL Refractories
What does IFGL Refractories Ltd do?
Where is IFGL Refractories Ltd (IFGLEXPOR) listed?
Which sector does IFGL Refractories Ltd belong to?
What is the PE ratio of IFGL Refractories Ltd?
What is the 52-week high and low of IFGL Refractories Ltd?
Does IFGL Refractories Ltd pay dividends?
What is the Return on Equity (ROE) of IFGL Refractories Ltd?
Company Information
IFGL Refractories Ltd is a manufacturer of Specialized refractories and requisite operating systems for Iron and Steel Industry. It is promoted by the S.K. Bajoria Group of India and Krosaki Harima Corporation of Japan, a global leader in the refractories business.
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/IFGLEXPOR.md for IFGL Refractories Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.